Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Compounded GLP-1 Guidepricing database · evidence ledger

Authors & reviewers

Jonathan Snipes, MD

Medical Reviewer

Jonathan Snipes, MD is the physician medical reviewer for Compounded GLP-1 Guide. He reviews clinical guides, safety content, and any page making medication-specific claims, checking mechanism, indication, contraindication, and risk language against FDA labeling and the primary clinical literature. His NPI record (1821250077) is listed in the CMS National Plan and Provider Enumeration System (NPPES) registry.

Credentials & verification

Jonathan Snipes, MD — role and verification
RoleMedical Reviewer
Review scopePhysician-level medical review: medication guides, safety pages, dosing context, and regulatory-status language.
NPI1821250077 — verified in the CMS National Plan & Provider Enumeration System (NPPES) registry
VerificationNPI record checked against the CMS NPPES registry as of 2026-07-20. The public NPPES taxonomy is the authoritative source for licensure and specialty.

What this reviewer signs

As physician medical reviewer, Jonathan Snipes, MD is the named reviewer responsible for medication guides, safety pages, dosing-context, and regulatory-status language. Pages in those categories name him as the accountable medical reviewer.

← All authors & reviewers · Publisher: US Peptides Partners LLC. This profile lists only confirmed information; nothing beyond the verified facts above is asserted. See the About page for ownership and the corrections route.